Le Lézard
Classified in: Health, Science and technology
Subject: MRR

United States Biobanks Market Report 2021

DUBLIN, Sept. 24, 2021 /PRNewswire/ -- The "United States Biobanks Market, By Type (Population Based Biobanks v/s Disease Oriented Biobanks), By Ownership, By Product, By Specimen Type, By Application, By End User, By Region, Competition Forecast & Opportunities, 2026" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

United States biobanks market is expected to grow at a significant rate during the forecast period.

Growing need to store and preserve the biological samples such as nucleic acids, tissues, blood which are in demand for research activities for advancements in biomedical research and identify disease-relevant biomarkers.

The rise in the number of research activities is considered the major driver for the forecast period. An increase in investments and funding made by the leading authorities and market players to advance the sectors such as regenerative medicine, cell & gene therapy, stem cell therapeutics is promoting the scope of research activities which in turn is accelerating the market growth.

The surge in the adoption of cord blood banking techniques by healthcare facilities offers several benefits such as more people can receive stem cells than received through the bone marrow and this process is less complicated and painful for the donor which in turn is fostering the growth of the biobanks market.

Biobanks play a significant role to maintain and update the age demographic databases. The rising demand for personalized medicine as it is considered more effective and provides better results is contributing to the surge in the biobanks market growth.

United States biobanks market is segmented into type, ownership, product, specimen type, application, end user, regional distribution, and company. Based on product, the market can be divided into equipment & consumables, media, software & services.

The equipment & consumables product segment is expected to hold a major market share in the forecast period. The rise in the number of biobanks is aiding to increase the capacity to store a large number of biosamples is increasing the demand for biobanking devices which in turn is accelerating the market growth.

Major companies are developing advanced technologies and launching new services to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new service developments.

Objective of the Study:

The major players operating in the United States biobanks market are 

Report Scope:

Years considered for this report:

United States Biobanks Market, By Type:

United States Biobanks Market, By Ownership:

United States Biobanks Market, By Product:

United States Biobanks Market, By Specimen Type:

United States Biobanks Market, By Application:

United States Biobanks Market, By End User:

United States Biobanks Market, By Region:

For more information about this report visit https://www.researchandmarkets.com/r/plormq

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

These press releases may also interest you

at 11:18
Two local leaders in mental health have joined forces and voices to create a new platform for learning, healing, hope, and wellness in San Diego and beyond.  'The Mind Collective' is a partnership between the National...

at 11:15
Anthem Blue Cross and Blue Shield Foundation, a long-time partner of An Achievable Dream (AAD), renewed its support for the 2021-2022 year with a $100,000 grant. The Foundation is committed to partnering with organizations like AAD to provide...

at 11:12
Medivir AB today announces that the nomination committee now has been appointed ahead of the Annual General Meeting in May 2022. According to an AGM resolution, the Nomination Committee 2021-2022 should consist of representatives of at least the...

at 11:10
CytoDyn Inc. (the "Company"), a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, today convened and then adjourned the 2021 Annual Meeting of Shareholders (the "Annual...

at 11:05
NRGene , a leading genomics company, announces the official opening of its new office and genotyping lab in Saskatoon, Canada. The opening event will take place today in the Innovation Research Park, in the presence of members of legislative assembly...

at 11:01
Advanced Ultrasound Systems (AUS), a leading provider of ultrasound equipment, parts, service, and training announced today its 20th anniversary celebration with reflections on what the organization has accomplished over the past two decades. Since...

News published on 24 september 2021 at 08:45 and distributed by: